Bone loss in young women with karyotypically normal spontaneous premature ovarian failure

Obstetrics and Gynecology

Volumn 91, Issue 1, 1998, Pages 12-15

  Anasti, James N ^a   Kalantaridou, Sophia N ^a   Kimzey, Lorene M ^a   Defensor, Rubi A ^a   Nelson, Lawrence M ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; BONE ATROPHY; BONE DENSITY; BONE MINERAL; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN THERAPY; FEMALE; FEMUR NECK; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MENSTRUATION; OVARY FUNCTION; OVARY INSUFFICIENCY; PRIORITY JOURNAL;

EID: 0031972892     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00583-8     Document Type: Article

References (20)

1. 1. Rodin A, Murby B, Smith MA, Caleffi M, Fentiman I, Chapman MG, et al. Premenopausal bone loss in the lumbar spine and neck of femur: A study of 225 Caucasian women. Bone 1990;11:1-5.
2. 2. Rizzoli R, Bonjour JP. Hormones and bones. Lancet 1997;349 Suppl 1:20-3.
3. 3. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604-6.
4. 4. Nelson LM, Anasti JN, Flack MR. Premature ovarian failure. In: Adashi EY, Rock JA, Rozenwaks Z, eds. Reproductive endocrinology, surgery, and technology. Philadelphia: Lippincott-Raven, 1996:1394-410.
5. 5. Bermudez JA, Moran C, Herrera J, Barahona E, Perez MC, Zarate A. Determination of the steroidogenic capacity in premature ovarian failure. Fertil Steril 1993;60:668-71.
6. 6. Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HS. Characterization of idiopathic premature ovarian failure. Fertil Steril 1996; 65:337-41.
7. 7. Ohta H, Sugimoto I, Masuda A, Komukai S, Suda Y, Makita K, et al. Decreased bone mineral density associated with early menopause progresses for at least ten years: Cross-sectional comparisons between early and normal menopausal women. Bone 1996; 18:227-31.
8. 8. Bagur AC, Mautalen CA. Risk for developing osteoporosis in untreated premature menopause. Calcif Tissue Int 1992;51:4-7.
9. 9. Kim TJ, Anasti JN, Flack MR, Kimzey LM, Defensor RA, Nelson LM. Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 1997;89:777-9.
10. 10. Mazess RB, Barden HS, Ettinger M, Johnston C, Dawson-Hughes B, Baran D, et al. Spine and femur density using dual-photon absorptiometry in US white women. Bone Min 1987;2:211-9.
11. 11. Sachs L. Applied statistics. 2nd ed. New York: Springer-Verlag, 1984.
12. 12. Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646-50.
13. 13. Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, et al. Bone density at various sites for prediction of hip fractures. Lancet 1993;341:72-7.
14. 14. Prior JC, Vigna YM, Schechter MT, Burgess AE. Spinal bone loss and ovulatory disturbances. N Engl J Med 1990;323:1221-7.
15. 15. The Writing Group for the PEPI trial. Effects of hormone therapy on bone mineral density: Results from the postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA 1996;276: 1389-96.
16. 16. Lindsay R, Hart DM, Clark DM. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 1984;63:759-63.
17. 17. Sugimoto AK, Hodsman AB, Nisker JA. Long-term gonadotropinreleasing hormone agonist with standard postmenopausal estrogen replacement failed to prevent vertebral bone loss in premenopausal women. Fertil Steril 1993;60:672-4.
18. 18. Slemenda C, Longcope C, Peacock M, Hui S, Johnston CC. Sex steroids, bone mass and bone loss. A prospective study of pre-, peri-, and postmenopausal women. J Clin Invest 1996;97:14-21.
19. 19. Watts NB, Notelovitz M, Timmons MC, Addison WA, Wiita B, Downey LJ. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol 1995;85:529-37.
20. 20. Savvas M, Studd JWW, Norman S, Leather AT, Garnett TJ, Fogelman I. Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in postmenopausal women who have previously received long-term oral oestrogens. Br J Obstet Gynaecol 1992;99:757-60.